Last reviewed · How we verify
NCT04702061
Comparison of Erector Spina Plane Block and Thoracic Epidural Block
NA trial testing Erector spina plane block before general anaesthesia in Breast Neoplasms in 20 participants. Completed in 31 March 2021.
31 March 2021
Quick facts
| Lead sponsor | Inonu University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 11 January 2021 |
| Primary completion | 31 March 2021 |
| Estimated completion | 31 March 2021 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Erector spina plane block before general anaesthesia
- Thoracic epidural block before general anaesthesia
Conditions studied
- Breast Neoplasms — all drugs for Breast Neoplasms →
- Pain, Postoperative — all drugs for Pain, Postoperative →
Sponsor
Inonu University
Who can join
Adults 18 to 70, female only, with Breast Neoplasms or Pain, Postoperative. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this randomised controlled and double-blind study, is to compare the effects of erector spinae plane (ESP) and thoracic epidural (TEA) blocks on peri-operative hemodynamics and analgesia in patients undergoing unilateral mastectomies due to malignancy.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparison of sympathetic block and hemodynamic effects of erector spinae plane block and thoracic epidural analgesia in breast surgery: a randomised controlled trial.
Kurada G, Erdoğan Kayhan G, Şanal S, Onay M, et al · · 2026 · PMID 41691173 · DOI 10.1186/s12871-026-03694-2
Verify or expand the search:
- PubMed search for NCT04702061
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breast Neoplasms
Currently open trials in the same condition.
- NCT07214532 — Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer · NA · recruiting
- NCT07500428 — Construction of a Benchmark for Breast Ultrasound AI Interpretation and Performance Evaluation of Multimodal AI Models · recruiting
- NCT07581834 — Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multic · Phase 2 · recruiting
- NCT07222215 — PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA) · Phase 2 · recruiting
- NCT07465393 — Facility-Based Multi-Modal Rehab vs. Home-Based Resistance Exercise for Quality of Life in Breast Cancer Survivors · NA · recruiting
Other Inonu University trials
Trials by the same sponsor.
- NCT06553807 — Genital Self İmage and Satisfaction With Genital Appearance · NA · not yet recruiting
- NCT07480122 — Motor Imaging, Neglect, and Upper Extremity Function in Stroke · not yet recruiting
- NCT07463326 — The Efficacy of Transcutaneous Tibial Nerve Stimulation in Women With Idiopathic Overactive Bladder · NA · enrolling by invitation
- NCT07510737 — The Effect of Cross Training on Clinical and Functional Outcomes in Frozen Shoulder Rehabilitation · not yet recruiting
- NCT07530211 — The Effect of Systemic Factors on Peri-implant Health Status and Clinical Indices · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04702061 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Inonu University
- Last refreshed: 20 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04702061.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing